Expansion of tumor-reactive CD8
Journal
Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624
Informations de publication
Date de publication:
13 Sep 2024
13 Sep 2024
Historique:
medline:
13
9
2024
pubmed:
13
9
2024
entrez:
13
9
2024
Statut:
ppublish
Résumé
Immune checkpoint blockade (ICB) enhances T cell responses against cancer, leading to long-term survival in a fraction of patients. CD8
Identifiants
pubmed: 39270006
doi: 10.1126/sciimmunol.adi3487
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM